Investigational New Drugs,volume 23,issue 6  (12-2014)

Period of time: 2014年6期

Publisher: Springer Publishing Company

Founded in: 1983

Total resources: 32

ISSN: 0167-6997

Subject: R9 Pharmacy

Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Investigational New Drugs,volume 23,issue 6

Menu

Randomized phase II trial of different schedules of administration of rebeccamycin analogue as second line therapy in non-small cell lung cancer

By Dowlati Afshin,Chapman Robert,Subbiah Shanmuga,Fu Pingfu,Ness Anne,Cortas Tania,Patrick Lauren,Reynolds Sherrie,Xu Natalie,Levitan Nathan,Ivy Percy,Remick Scot in (2005)

Investigational New Drugs,volume 23,issue 6 , Vol. 23, Iss. 6, 2005-12 , pp. 563-567

Springer Publishing Company

Abstract Access to resources Recommend Favorite

Phase II Study of Perifosine in Previously Untreated Patients with Metastatic Melanoma

By Ernst D,Eisenhauer Elizabeth,Wainman Nancy,Davis Mary,Lohmann Reinhard,Baetz Tara,Belanger Karl,Smylie Michael in (2005)

Investigational New Drugs,volume 23,issue 6 , Vol. 23, Iss. 6, 2005-12 , pp. 569-575

Springer Publishing Company

Abstract Access to resources Recommend Favorite